Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/1998
06/02/1998US5759528 Topical composition for promoting transdermal absorption of therapeutic agents
06/02/1998US5759519 Method for the intracellular delivery of biomolecules using thiocationic lipids
06/02/1998US5759517 Hemoglobins as drug delivery agents
05/1998
05/28/1998WO1998022610A1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
05/28/1998WO1998022512A1 Water soluble lipidated arabinogalactan
05/28/1998WO1998022508A2 Process for tumour cell depletion of cd34-positive cells
05/28/1998WO1998022149A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33
05/28/1998WO1998022141A2 Enhanced effects for hapten conjugated therapeutics
05/28/1998WO1998022140A2 Hybrid compositions for intracellular targeting
05/28/1998WO1998022136A2 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies
05/28/1998WO1998022113A1 Methods of prevention and treatment of ischemic damage
05/28/1998WO1998022107A1 Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation
05/28/1998WO1998022106A1 Pharmaceutical composition
05/28/1998WO1998022105A1 Tabletted preparation
05/28/1998WO1998022094A2 Method for producing shaped and unshaped polyol masses
05/28/1998WO1998022093A1 Process for the preparation of a controlled release system
05/28/1998WO1998022092A1 Transport of liposomes across the blood-brain barrier
05/28/1998WO1998022090A1 Treatment of equine laminitis
05/28/1998WO1998022083A1 Therapeutic and cosmetic compositions, their use and method for the preparation thereof
05/28/1998WO1998021951A1 Methods and compositions for inducing oral tolerance in mammals
05/28/1998WO1998002191A3 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
05/28/1998DE19648209A1 Verfahren zur Tumorzelldepletion CD34-positiver Zellen Method for Tumorzelldepletion CD34-positive cells
05/28/1998CA2273183A1 Treatment of equine laminitis
05/28/1998CA2272747A1 Hybrid compositions for intracellular targeting
05/28/1998CA2272362A1 Water soluble lipidated arabinogalactan
05/28/1998CA2272093A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33
05/28/1998CA2271839A1 Process for the production of shaped or unshaped polyol materials
05/28/1998CA2271273A1 Methods of prevention and treatment of ischemic damage
05/28/1998CA2267833A1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
05/28/1998CA2243643A1 Methods and compositions for inducing oral tolerance in mammals
05/28/1998CA2220534A1 Aqueous dispersion of vesicles resistant to dehydration
05/27/1998EP0844269A1 Block polymer having functional groups at both ends
05/27/1998EP0844016A2 Polyoxyethylene fatty acid ester surfactants and use thereof
05/27/1998EP0844004A1 Gene preparations
05/27/1998EP0843565A1 Coarse spray delivery of functional biologic materials
05/27/1998EP0843560A1 Cellulose diacetate compositions for use in embolizing blood vessels
05/27/1998EP0843559A2 Chitosan drug delivery system
05/27/1998EP0843558A2 Composition for enhanced uptake of polar drugs from the colon
05/27/1998EP0843556A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions
05/27/1998EP0843552A2 Pharmaceutical formulations
05/27/1998EP0843548A2 Stabilized steroid compositions
05/27/1998EP0664697B1 Ranitidine chewable tablets
05/27/1998EP0656889B1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs
05/27/1998EP0618800B1 Glycosylated steroid derivatives for transport across biological membranes and process for making same
05/27/1998CN1183103A Peptide compositions with growth factor-like activity
05/27/1998CN1183040A Polyaminoacid-based particles for use as active principle vectors, and methods for preparing same
05/27/1998CN1183039A Novel collagen formulations
05/27/1998CN1182592A Stable prostaglandin E1-containing injectable composition
05/26/1998US5756818 Hydrogenation; protecting; deprotecting; clathrates
05/26/1998US5756723 Metal-mediated cross-coupling with ring-metalated porphyrins
05/26/1998US5756699 Immunotoxins comprising ribosome-inactivating proteins
05/26/1998US5756685 Medical diagnosis; therapy
05/26/1998US5756552 Mixture of drug, methyl cellulose, citric acid and polyethylene glycol
05/26/1998US5756546 Water-soluble nimesulide salt and its preparation, aqueous dolution containing it, nimesulide-based combinations and their uses
05/26/1998US5756543 Bitterness-relieving agent
05/26/1998US5756483 Pharmaceutical compositions for intranasal administration of apomorphine
05/26/1998US5756474 Non-aqueous oral-drench compositions containing avermectin compounds
05/26/1998US5756468 Lyophilized solid drug consists of a compound having botulinum toxicity, stabilizing protein, polysaccharide sugar and thioalkyl compound selected from methionine and cysteine; storage stability
05/26/1998US5756457 Neural regeneration using human bone morphogenetic proteins
05/26/1998US5756353 Introducing dna into cell of proximal or distal airways of a mammal by administering aerosol lipid-dna complex
05/26/1998US5756121 Forming liposomes for treatment of drug resistant bacteria
05/26/1998US5756119 Aqueous carrier containing active ingredient, nonionic polyacrylamide predispersed in water-immiscible oil containing surfactant
05/26/1998US5756118 Enhanced skin penetration system for improved topical delivery of drugs
05/26/1998US5756108 Containing particles formed of phytanetriol or n-2-alkoxycarbonyl derivative of n-methylglucamine, water soluble surfactant as dispersing and stabilizing agent
05/22/1998WO1998021311A1 Compositions and methods relating to the production, isolation, and modification of gas vesicles
05/22/1998WO1998020964A2 Novel fatty alcohol sulfates and alkylethersulfates with trialkylammonium counter-ions and well as their production and use
05/22/1998WO1998020917A2 Hydrophilic polystyrene graft copolymer vehicle for intravaginal administration of pharmacologically active agents
05/22/1998WO1998020905A2 Treatment of iron overload disorders
05/22/1998WO1998020887A1 Polyphosphoinositide binding peptides for intracellular drug delivery
05/22/1998WO1998020873A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
05/22/1998WO1998020870A1 Improved treatment of migraine headache
05/22/1998WO1998020869A2 Formulation for electrically assisted delivery of lidocaine and epinephrine
05/22/1998WO1998020862A1 Immediate wettability water soluble film or water soluble layer for oral application
05/22/1998WO1998020858A1 COMPACT MEMBER COMPRISING A PLURALITY OF POROUS CELLULOSE MATRICES, (PCMs), METHOD OF MANUFACTURING AND USE THEREOF
05/22/1998WO1998020857A1 Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
05/22/1998WO1998020852A1 Pharmaceutical compositions containing kukui nut oil
05/22/1998WO1998011920A3 Method of capture of a bioactive agent by a nanoerythrosome preparation
05/22/1998WO1998010795A3 Tumor homing molecules, conjugates derived therefrom, and methods of using same
05/22/1998WO1998001555A3 Truncated soluble tumor necrosis factor type-i and type-ii receptors
05/22/1998CA2271724A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
05/22/1998CA2271652A1 Compact member comprising a plurality of porous cellulose matrices, (pcms), method of manufacturing and use thereof
05/22/1998CA2271325A1 Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
05/20/1998EP0842662A1 Percutaneous tape preparation containing fentanyl
05/20/1998EP0842658A1 Photostable aqueous solution containing benzyl alcohol derivatives
05/20/1998EP0842657A1 Microspheres for controlled release and processes to prepare these microspheres
05/20/1998EP0842435A1 Stabilized aqueous steroid immunoassay standards with cyclodextrins
05/20/1998EP0842209A2 Multiblock biodegradable hydrogels for use as controlled release agents for drugs and tissue treatment agents
05/20/1998EP0841951A2 Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
05/20/1998EP0841949A2 Saccharide conjugates
05/20/1998EP0841948A1 Composition containing a nerve fibre reactivity modulating compound
05/20/1998EP0841946A1 Methods for treatment of allergic asthma
05/20/1998EP0841932A1 Drug delivery enhancement via modified saponins
05/20/1998EP0841930A1 Stable solid formulation of enalapril salt and process for preparation thereof
05/20/1998EP0841905A1 Hard gelatin capsules with low water transport and process for the production thereof
05/20/1998EP0841901A1 Polymeric drug formulations
05/20/1998EP0841854A1 Novel compositions for use in embolizing blood vessels
05/20/1998EP0824545A4 Peptide compositions with growth factor-like activity
05/20/1998EP0782448A4 Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
05/20/1998EP0691992B1 Random block copolymers
05/20/1998EP0548157B1 Use of particulate agents
1 ... 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 ... 1712